New from NICE

This clinical guideline updates and replaces the 2007 guideline on secondary prevention (CG48) and the technology appraisal of clopidogrel (TA80). Most of the changes reflect new thinking about drug therapy.

New from NICE

Add yours ↓
Web design and marketing agency Leamington Spa